Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity · Investor's Business Daily

In This Article:

Biohaven stock tumbled for the second day running Tuesday after its bipolar mania treatment failed in a three-week study.